Search Results - Mark Biagi

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing <i>Enterobacteriaceae</i>

    Exploring Aztreonam in Combination with Ceftazidime-Avibactam or Meropenem-Vaborbactam as Potential Treatments for Metallo- and Serine-β-Lactamase-Producing <i>Enterobacteriaceae</... by Mark Biagi, Ting Wu, Migyung Lee, Shitalben Patel, David A. Butler, Eric Wenzler

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat

    Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat by David A. Butler, Mark Biagi, Xing Tan, Samah Qasmieh, Zackery P. Bulman, Eric Wenzler

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole

    Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole by Mark Biagi, X. Tan, Tian-Shung Wu, M. Jurkovic, A. Vialichka, K. Meyer, Rodrigo E. Mendes, Eric Wenzler

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia

    Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophi... by Mark Biagi, A. Vialichka, M. Jurkovic, Tian-Shung Wu, Aisha Shajee, Migyung Lee, Shitalben Patel, Rodrigo E. Mendes, Eric Wenzler

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria

    Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria by Mark Biagi, Nathan P. Wiederhold, Connie Fe C. Gibas, Brian L. Wickes, Victoria María Bamond Lozano, Susan C Bleasdale, Larry H. Danziger

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

    Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study by Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, A. Taqi, Abdalhamid M Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Monica V. Mahoney, Wesley D. Kufel, Joseph A. D’Antonio, Bruce M Jones, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P. Veve, Michael J. Rybak

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii

    Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii by Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, Leonor M. Rojas, Madeline King, Benjamin Pullinger, Athena L V Hobbs, Nicholson B. Perkins, Michael P. Veve, Jeannette Bouchard, Tristan Gore, Bruce M Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S. Lena Kang‐Birken, Kyle C. Molina, Mark Biagi, Michael Pierce, Marco R. Scipione, Jing Zhao, Susan L. Davis, Michael J. Rybak

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    P-1500. Evaluation of Imipenem-cilastatin-relebactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>

    P-1500. Evaluation of Imipenem-cilastatin-relebactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i> by Kaylee E Caniff, Xhilda Xhemali, Nikki Tran, Taryn A Eubank, Kevin W. Garey, Yi Guo, Mei H. Chang, Katie E. Barber, Mark Biagi, Travis J Carlson, Jeremy J Frens, Tamara Krekel, Veena Venugopalan, Wesley D. Kufel, Amy Carr, Jillian E Hayes, James M. Sanders, Elisabeth Chandler, Rosanna Li, Julie Ann Justo, Kayla Antosz, Russell J Benefield, William J Moore, Jennifer Ross, Athena L V Hobbs, Nicholas J. Mercuro, Brian R. Raux, Kristen Zeitler, Michael J. Rybak

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Real-World Applications of Imipenem/Cilastatin/Relebactam: Insights from a Multicenter Observational Cohort Study

    Real-World Applications of Imipenem/Cilastatin/Relebactam: Insights from a Multicenter Observational Cohort Study by Kaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, Nikki Tran, Taryn A Eubank, Kevin W. Garey, Yi Guo, Mei H. Chang, Katie E. Barber, Tamara Krekel, Mark Biagi, Wesley D. Kufel, Amy Carr, Jillian E Hayes, Travis J Carlson, Jeremy J Frens, Veena Venugopalan, Kristen Lucas, Ashlan J. Kunz Coyne, James M. Sanders, Elisabeth Chandler, Rosanna Li, Kayla Antosz, Julie Ann Justo, Russell J Benefield, William J Moore, Jennifer Ross, Jenna C. Adams, Fritzie S Albarillo, Sylvia S. Stefanos, Athena L V Hobbs, Nicholas J. Mercuro, Brian R. Raux, Kristen Zeitler, Michael J. Rybak

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: